Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;24(5):565-575.
doi: 10.2174/1566524023666230523155719.

Non-coding RNAs in Precursor Lesions of Colorectal Cancer: Their Role in Cancer Initiation and Formation

Affiliations
Review

Non-coding RNAs in Precursor Lesions of Colorectal Cancer: Their Role in Cancer Initiation and Formation

Somayeh Mohammadpour et al. Curr Mol Med. 2024.

Abstract

Colorectal cancer (CRC) is one of the world's most common types of malignancy. The proliferation of precancerous lesions causes this type of cancer. Two distinct pathways for CRC carcinogenesis have been identified: the conventional adenoma-carcinoma pathway and the serrated neoplasia pathway. Recently, evidence has demonstrated the regulatory roles of noncoding RNAs (ncRNAs) in the initiation and progression of precancerous lesions, especially in the adenoma-carcinoma pathway and serrated neoplasia pathway. By expanding the science of molecular genetics and bioinformatics, several studies have identified dysregulated ncRNAs that function as oncogenes or tumor suppressors in cancer initiation and formation by diverse mechanisms via intracellular signaling pathways known to act on tumor cells. However, many of their roles are still unclear. This review summarizes the functions and mechanisms of ncRNAs (such as long non-coding RNAs, microRNAs, long intergenic non-coding RNAs, small interfering RNAs, and circRNAs) in the initiation and formation of precancerous lesions.

Keywords: Noncoding RNAs; cancer.; colorectal neoplasms; mechanism; precancerous; precursor lesion.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Sung H.; Ferlay J.; Siegel R.L.; Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021,71(3),209-249 - DOI - PubMed
    1. Onyoh E.F.; Hsu W.F.; Chang L.C.; Lee Y.C.; Wu M.S.; Chiu H.M.; The rise of colorectal cancer in Asia: epidemiology, screening, and management. Curr Gastroenterol Rep 2019,21(8),36 - DOI - PubMed
    1. Ønes M.; Helsingen LM.; Bretthauer M.; Emilsson L; Epidemiology and risk factors of colorectal polyps. Best Pract Res Clin Gastroenterol 2017,31(4),419-424 - DOI - PubMed
    1. Malki A.; ElRuz R.A.; Gupta I.; Allouch A.; Vranic S.; Al Moustafa A.E.; Molecular mechanisms of colon cancer progression and metastasis: Recent insights and advancements. Int J Mol Sci 2020,22(1),130 - DOI - PubMed
    1. Nikolouzakis T.; Vassilopoulou L.; Fragkiadaki P.; Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients. (Review) Oncol Rep 2018,39(6),2455-2472 - DOI - PubMed

Publication types

MeSH terms